| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.0039 | 1 |